RedHill Biopharma (2RH) Q3 2021 Earnings Report
5 Followers
DE:2RH Q3 2021 EPS Results
- Actual EPS
- -EUR 446.03
- Consensus EPS
- -EUR 423.09
- Beat/Miss
- Missed by -EUR 22.94
- One Year Ago EPS
- -EUR 446.03
DE:2RH Q3 2021 Revenue Results
- Actual Revenue
- EUR 19.37M
- Expected Revenue
- EUR 21.87M
- Beat/Miss
- Missed by -EUR 2.50M
- YoY Revenue Growth
- +2.87%
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 11/30/2021
- Time
- Before Open
- Conference Call
- Tuesday, November 30, 2021
DE:2RH Upcoming Earnings
RedHill Biopharma's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2RH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | ―- | ― | ― | ― |
| Sep 30, 2026 | 2026 (Q2) | ―-0.90 | -2.07 | 56.56% (+1.17) | |
| Apr 27, 2026 | 2025 (Q4) | ―- | ― | ― | |
| Sep 05, 2025 | 2025 (Q2) | ―-2.07 | 0 | ― | |
| May 13, 2025 | 2025 (Q1) | ―- | ― | ― | |
| Apr 10, 2025 | 2024 (Q4) | ―- | ― | ― | |
| Aug 29, 2024 | 2024 (Q2) | ―0.00 | 0.89 | -100.00% (-0.89) | |
| May 07, 2024 | 2024 (Q1) | ―- | ― | ― | |
| Apr 08, 2024 | 2023 (Q4) | ―- | -0.04 | ― | |
| Nov 15, 2023 | 2023 (Q3) | ―0.04 | -2.14 | 101.67% (+2.18) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
